Logotype for Alaunos Therapeutics Inc

Alaunos Therapeutics (TCRT) Proxy Filing summary

Event summary combining transcript, slides, and related documents.

Logotype for Alaunos Therapeutics Inc

Proxy Filing summary

1 Dec, 2025

Executive summary

  • The annual meeting will be held virtually on July 3, 2025, with voting on seven key proposals, including director elections, auditor ratification, executive compensation, a reverse stock split, an increase in authorized shares, an equity plan amendment, and potential adjournment.

  • Only shareholders of record as of May 5, 2025, are eligible to vote, with multiple voting methods available, including online, phone, and mail.

  • The Board unanimously recommends voting in favor of all proposals.

  • Forward-looking statements highlight risks and uncertainties, especially regarding compliance with Nasdaq listing standards and the company’s ability to raise capital.

Voting matters and shareholder proposals

  • Proposal 1: Election of four directors to serve until 2026.

  • Proposal 2: Ratification of Cherry Bekaert LLP as independent auditor for 2025.

  • Proposal 3: Advisory vote on executive compensation (say-on-pay).

  • Proposal 4: Authorization for a reverse stock split at a ratio of 1-for-5 to 1-for-20, at Board discretion, to maintain Nasdaq compliance.

  • Proposal 5: Increase authorized common stock from 5,000,000 to 50,000,000 shares.

  • Proposal 6: Amend the 2020 Equity Incentive Plan to increase shares available for issuance from 130,745 to 1,130,745.

  • Proposal 7: Adjournment of the meeting if more time is needed to solicit votes.

  • Shareholder proposals for the 2026 meeting must be submitted by January 19, 2026.

Board of directors and corporate governance

  • The Board consists of four directors, with a majority deemed independent under Nasdaq rules.

  • Board leadership is separated between the Chair and the interim CEO to reinforce independence.

  • Three standing committees: audit, compensation, and corporate governance/nominating, all with independent members.

  • The Board emphasizes diversity, integrity, and relevant experience in director nominations.

  • Corporate governance documents, code of ethics, whistleblower, and clawback policies are in place.

Partial view of Summaries dataset, powered by Quartr API
AI can get things wrong. Verify important information.
All investor relations material. One API.
Learn more